Assessing the Impact of Morphine on Adverse Outcomes in ACS Patients Treated with P2Y12 Inhibitors: Insights from Multiple Real-World Evidence

References

• Bhatt DL, Lopes RD, Harrington RA. Diagnosis and treatment of acute coronary syndromes: a review. JAMA. 2022;327(7):662–675. doi:10.1001/jama.2022.0358
   PubMed Web of Science ®Google Scholar
• Komócsi A, Merkely B, Hadamitzky M, et al. Impact of body mass on P2Y12-inhibitor de-escalation in acute coronary syndromes-a substudy of the TROPICAL-ACS trial. Eur Heart J Cardiovasc Pharmacother. 2023;9(7):608–616. doi:10.1093/ehjcvp/pvad027
   PubMed Web of Science ®Google Scholar
• Qu J, Zhang D, Zhang H, et al. Preoperative clopidogrel and outcomes in patients with acute coronary syndrome undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2022;163(3):1044–1052. doi:10.1016/j.jtcvs.2020.03.118
   PubMed Web of Science ®Google Scholar
• Kubica J, Adamski P, Ostrowska M, et al. Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial. Eur Heart J. 2016;37(3):245–252. doi:10.1093/eurheartj/ehv547
   PubMed Web of Science ®Google Scholar
• Hobl EL, Stimpfl T, Ebner J, et al. Morphine decreases clopidogrel concentrations and effects: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol. 2014;63(7):630–635. doi:10.1016/j.jacc.2013.10.068
   PubMed Web of Science ®Google Scholar
• Meine TJ, Roe MT, Chen AY, et al. Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE quality improvement initiative. Am Heart J. 2005;149(6):1043–1049. doi:10.1016/j.ahj.2005.02.010
   PubMed Web of Science ®Google Scholar
• Furtado RHM, Nicolau JC, Guo J, et al. Morphine and cardiovascular outcomes among patients with non-ST-segment elevation acute coronary syndromes undergoing coronary angiography. J Am Coll Cardiol. 2020;75(3):289–300. doi:10.1016/j.jacc.2019.11.035
   PubMed Web of Science ®Google Scholar
• Böhm R, von Hehn L, Herdegen T, et al. OpenVigil FDA - inspection of U.S. American adverse drug events pharmacovigilance data and novel clinical applications. PLoS One. 2016;11(6):e0157753. doi:10.1371/journal.pone.0157753
   PubMed Web of Science ®Google Scholar
• Palevsky PM, Liu KD, Brophy PD, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis. 2013;61(5):649–672. doi:10.1053/j.ajkd.2013.02.349
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018;72(18):2231–2264. doi:10.1016/j.jacc.2018.08.1038
   PubMed Web of Science ®Google Scholar
• Liu S, Wu X, Lopez AD, et al. An integrated national mortality surveillance system for death registration and mortality surveillance, China. Bull World Health Organ. 2016;94(1):46–57. doi:10.2471/BLT.15.153148
   PubMed Web of Science ®Google Scholar
• Montalescot G, van T HA, Lapostolle F, et al. Prehospital ticagrelor in ST-segment elevation myocardial infarction. N Engl J Med. 2014;371(11):1016–1027. doi:10.1056/NEJMoa1407024
   PubMed Web of Science ®Google Scholar
• Eitel I, Wang J, Stiermaier T, et al. Impact of morphine treatment on infarct size and reperfusion injury in acute reperfused ST-elevation myocardial infarction. J Clin Med. 2020;9(3). doi:10.3390/jcm9030735.
   Web of Science ®Google Scholar
• Puymirat E, Lamhaut L, Bonnet N, et al. Correlates of pre-hospital morphine use in ST-elevation myocardial infarction patients and its association with in-hospital outcomes and long-term mortality: the FAST-MI (French Registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction) programme. Eur Heart J. 2016;37(13):1063–1071. doi:10.1093/eurheartj/ehv567
   PubMed Web of Science ®Google Scholar
• Tsai TT, Patel UD, Chang TI, et al. Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR cath-PCI registry. JACC Cardiovasc Interv. 2014;7(1):1–9. doi:10.1016/j.jcin.2013.06.016
   PubMed Web of Science ®Google Scholar
• Park S, Lee S, Kim Y, et al. Nonlinear causal effects of estimated glomerular filtration rate on myocardial infarction risks: Mendelian randomization study. BMC Med. 2022;20(1):44. doi:10.1186/s12916-022-02251-1
   PubMed Web of Science ®Google Scholar
• Okubo K, Kurosawa M, Kamiya M, et al. Macrophage extracellular trap formation promoted by platelet activation is a key mediator of rhabdomyolysis-induced acute kidney injury. Nat Med. 2018;24(2):232–238. doi:10.1038/nm.4462
   PubMed Web of Science ®Google Scholar
• Yang J, Miao X, Guan Y, et al. Microbubble functionalization with platelet membrane enables targeting and early detection of sepsis-induced acute kidney injury. Adv Healthc Mater. 2021;10(23):e2101628. doi:10.1002/adhm.202101628
   PubMed Web of Science ®Google Scholar
• Oishi S, Tsukiji N, Otake S, et al. Heme activates platelets and exacerbates rhabdomyolysis-induced acute kidney injury via CLEC-2 and GPVI/FcRγ. Blood Adv. 2021;5(7):2017–2026. doi:10.1182/bloodadvances.2020001698
   PubMed Web of Science ®Google Scholar
• Yang S, Huang X, Liao J, et al. Platelet-leukocyte aggregates - a predictor for acute kidney injury after cardiac surgery. Ren Fail. 2021;43(1):1155–1162. doi:10.1080/0886022X.2021.1948864
   PubMed Web of Science ®Google Scholar
• Hu H, Batteux F, Chéreau C, et al. Clopidogrel protects from cell apoptosis and oxidative damage in a mouse model of renal ischaemia-reperfusion injury. J Pathol. 2011;225(2):265–275. doi:10.1002/path.2916
   PubMed Web of Science ®Google Scholar
• Mallappallil M, Sabu J, Friedman EA, Salifu M. What do we know about opioids and the kidney? Int J Mol Sci. 2017;18(1):223. doi:10.3390/ijms18010223
   PubMed Web of Science ®Google Scholar
• Pi M, Nie S, Su L, et al. Risk of hospital-acquired acute kidney injury among adult opioid analgesic users: a multicenter real-world data analysis. Kidney Dis. 2023;9(6):517–528. doi:10.1159/000533556
   Google Scholar
• Bessman JD, Williams LJ, Gilmer PJ. Mean platelet volume. the inverse relation of platelet size and count in normal subjects, and an artifact of other particles. Am J Clin Pathol. 1981;76(3):289–293. doi:10.1093/ajcp/76.3.289
   PubMed Web of Science ®Google Scholar
• Jansen MPB, Florquin S, Roelofs JJTH. The role of platelets in acute kidney injury. Nat Rev Nephrol. 2018;14(7):457–471. doi:10.1038/s41581-018-0015-5
   PubMed Web of Science ®Google Scholar
• Kertai MD, Zhou S, Karhausen JA, et al. Platelet counts, acute kidney injury, and mortality after coronary artery bypass grafting surgery. Anesthesiology. 2016;124(2):339–352. doi:10.1097/ALN.0000000000000959
   PubMed Web of Science ®Google Scholar
• Verdoia M, Pergolini P, Rolla R, et al. Impact of long-term dual antiplatelet therapy on immature platelet count and platelet reactivity. Angiology. 2018;69(6):490–496. doi:10.1177/0003319717736407
   PubMed Web of Science ®Google Scholar
• Giustino G, Kirtane AJ, Généreux P, et al. Relation between platelet count and platelet reactivity to thrombotic and bleeding risk: from the assessment of dual antiplatelet therapy with drug-eluting stents study. Am J Cardiol. 2016;117(11):1703–1713. doi:10.1016/j.amjcard.2016.03.001
   PubMed Web of Science ®Google Scholar